Analytical Data
-
Gene name
BUD31
- Application
-
Alternative Names
BUD31；EDG2；Protein BUD31 homolog
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P41223
-
Expression Region
1-144aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPKVKRS RKAPPDGWEL IEPTLDELDQ KMREAETEPH EGKRKVESLW PIFRIHHQKT RYIFDLFYKR KAISRELYEY CIKEGYADKN LIAKWKKQGY ENLCCLRCIQ TRDTNFGTNC ICRVPKSKLE VGRIIECTHC GCRGCSG
-
Molecular Weight
19 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BUD31 is a protein associated with various cellular processes, particularly in the context of cell division and chromosomal maintenance. Its role has garnered attention due to its potential implications in understanding cancer biology and cellular dysfunctions. As a member of the BTB/POZ domain-containing protein family, BUD31 is believed to participate in the regulation of gene expression and protein interactions through its unique structural features. Research indicates that BUD31 may interact with key proteins involved in nucleic acid binding and chromatin remodeling, thereby influencing processes such as cell cycle progression and apoptosis. The study of BUD31, including its recombinant form, has gained traction in elucidating its function within cellular pathways and its contribution to tumorigenesis. By characterizing the recombinant BUD31 protein, researchers aim to gain insights into its biochemical properties and interactions, which could lead to the development of targeted therapeutic strategies. Understanding the mechanistic roles of BUD31 in both normal physiology and pathological conditions is crucial, as it may uncover novel biomarkers for cancer or other diseases, paving the way for advancements in personalized medicine.
